Salix Pharmaceuticals Ltd.
(NASDAQ : SLXP)

( )
SLXP After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.47%167.860.7%$1286.24m
PFEPfizer Inc. -0.99%39.190.9%$1246.10m
MRKMerck & Co., Inc. 0.19%77.850.7%$883.07m
ABBVAbbVie, Inc. 0.35%116.181.9%$725.90m
BMYBristol-Myers Squibb Co. -0.40%64.421.0%$715.35m
LLYEli Lilly & Co. 0.63%194.031.1%$594.24m
AZNAstraZeneca Plc -0.32%53.481.2%$547.21m
BTXBrooklyn ImmunoTherapeutics, Inc. -8.82%39.2912.8%$435.72m
GSKGlaxoSmithKline Plc 0.34%37.910.2%$193.13m
NVSNovartis AG 1.01%87.370.2%$170.78m
VTRSViatris, Inc. 2.13%13.930.0%$129.99m
CVACCureVac NV -7.16%93.950.0%$128.25m
MNMDMind Medicine (MindMed), Inc. 1.79%3.410.0%$89.63m
SNYSanofi 0.85%51.010.2%$65.50m
NVONovo Nordisk A/S 0.20%74.220.1%$61.85m

Company Profile

Salix Pharmaceuticals is a specialty pharmaceutical company committed to the prevention and treatment of gastrointestinal (GI) disorders. For more than 20 years, they have licensed, developed, and marketed innovative products to treat GI problems. It's their mission to give healthcare providers and patients the most effective solutions in gastroenterology.